Analysts rate the A2 Milk (ASX:A2M) share price as a buy

The A2 Milk Company Ltd (ASX:A2M) share price is rated as a buy by analysts. Could it be time to look at the company?

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The A2 Milk Company Ltd (ASX: A2M) share price has been through a lot of volatility since COVID-19 started.

But some analysts now see an opportunity with the infant formula and liquid milk company.

What has been going on with the A2 Milk share price?

Over the last year the A2 Milk share price has fallen by 56%. That makes it one of the worst performers in the ASX 200 (ASX: XJO) over that time period.

A2 Milk saw a huge demand for its products, namely its infant formula, in the early part of COVID as people stocked up their pantries.

In FY20, it saw total revenue of $1.73 billion, this was a rise of 32.8%. The net profit increased 34.1% to $385.8 million.

But FY21 saw the good numbers turn bad. Revenue fell 30.3% to $1.21 billion and net profit sank 79.1% to $80.7 million.

Several negative factors

online pharmacy zyprexa online with best prices today in the USA

worked together to hurt the A2 Milk share price and profit. There has been a huge slowdown of demand from the daigou/reseller channel. A2 Milk had too much inventory. Chinese customers have been buying more products from local Chinese brands.

Is it a buy?

According to reporting by the Australian Financial Reviewsome investors are now thinking that the A2 Milk share price may well be good value now.

The newspaper noted that fund manager Perpetual Limited (ASX: PPT) has been building a position in the business as it fell to approximately $5.50 per share.

It was also noted that the chief investment officer of 1851, Chris Stott, recently called A2 Milk a buy on a Livewire video, where he said:

“The a2 Milk Company has fallen from market darling to market dud, hasn’t it? So, that’s normally when you want to buy. 

online pharmacy desyrel with best prices today in the USA

We think that, at the moment, they’ve got through the worst in terms of their fall-away in earnings, particularly to China and the daigou channel, so we think they’re getting through the worst of that.”

online pharmacy buy neurontin online with best prices today in the USA

So is the A2 Milk share price an opportunity?

It could be. The business is still doing quite well with physical retailers in China, called mother and baby stores. The cross-border e-commerce (CBEC) channel could still do well over the long-term. But, there’s a chance that A2 Milk may never make the same profit from Chinese customers.

Plus, the lower A2 Milk share price certainly prices in a lot of the Chinese troubles. A2 Milk still has plenty of potential in Asia (excluding China), Australia, New Zealand, the US, Canada and any other regions it expands to.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.